Topics

FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market

10:09 EST 13 Feb 2020 | FDA

FDA has requested that the weight-loss drug Belviq, Belviq XR be withdrawn from the U.S. market because a safety clinical trial shows an increased occurrence of cancer. Stop taking the drug and talk to your health care professional if you have questions.

Original Article: FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market

NEXT ARTICLE

More From BioPortfolio on "FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...